IOIBD溃疡性直肠炎临床试验建议:PROCTRIAL共识
国际炎症性肠病组织(IOIBD)的PROCTRIAL共识通过改良德尔菲法形成溃疡性直肠炎临床试验的推荐意见。35名国际专家参与,共识定义为投票者中至少75%同意。共识明确诊断需经回结肠镜和组织病理学确认并排除其他病因,溃疡性直肠炎定义为病变宏观范围限于距肛缘15 cm以内的成人患者,并提出主要和次要终点。
要点
- 溃疡性直肠炎诊断需回结肠镜加组织病理学确认,并排除感染、药物、放射、外伤及克罗恩病。
- 溃疡性直肠炎定义为成人病变宏观范围限于距肛缘15 cm以内。
- 提出联合临床与内镜的主要终点评估疾病活动,次要终点包括内镜缓解、组织学缓解等。
核心结论
- PROCTRIAL共识针对溃疡性直肠炎临床试验的设计需求,提供了关于定义和终点的推荐意见。
研究设计与样本
- 35名国际专家召开共识会议,基于系统文献综述生成声明,采用改良德尔菲法讨论并批准,共识定义为投票者中至少75%同意。
主要发现
- 专家组同意溃疡性直肠炎诊断应由回结肠镜作出并经组织病理学确认,排除感染、药物诱导、放射、外伤和克罗恩病。
- 溃疡性直肠炎定义为成人病变宏观范围限于距肛缘15 cm以内。
- 确定了主要和次要终点以捕捉溃疡性直肠炎对治疗的反应,并提出联合临床与内镜的主要终点评估疾病活动。
- 应评估的次要终点包括内镜缓解、组织学缓解、黏膜愈合、组织学内镜黏膜改善、残疾、大便失禁、急迫感、便秘和健康相关生活质量。
关键数值与推荐
- 共识定义为投票者中至少75%同意。
- 溃疡性直肠炎定义:成人病变宏观范围限于距肛缘15 cm以内。
- 诊断需回结肠镜和组织病理学确认,排除感染、药物诱导、放射、外伤和克罗恩病。
- 提出联合临床与内镜的主要终点评估疾病活动。
- 次要终点包括内镜缓解、组织学缓解、黏膜愈合、组织学内镜黏膜改善、残疾、大便失禁、急迫感、便秘和健康相关生活质量。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Clinical trials evaluating biologics and small molecules in patients with ulcerative colitis are predominantly excluding ulcerative proctitis. The objective of the Definition and endpoints for ulcerative PROCtitis in clinical TRIALs initiative was to develop consensus statements for definitions, inclusion criteria, and endpoints for the evaluation of ulcerative proctitis in adults. METHODS: Thirty-five international experts held a consensus meeting to define ulcerative proctitis, and the endpoints to use in clinical trials. Based on a systematic review of the literature, statements were generated, discussed, and approved by the working group participants using a modified Delphi method. Consensus was defined as at least 75% agreement among voters. RESULTS: The group agreed that the diagnosis of ulcerative proctitis should be made by ileocolonoscopy and confirmed by histopathology, with the exclusion of infections, drug-induced causes, radiation, trauma, and Crohn's disease. Ulcerative proctitis was defined as macroscopic extent of lesions limited to 15 cm distance from the anal verge in adults. Primary and secondary endpoints were identified to capture response of ulcerative proctitis to therapy. A combined clinical and endoscopic primary endpoint for the evaluation of ulcerative proctitis disease activity was proposed. Secondary endpoints that should be evaluated include endoscopic remission, histologic remission, mucosal healing, histologic endoscopic mucosal improvement, disability, fecal incontinence, urgency, constipation, and health-related quality of life. CONCLUSIONS: In response to the need for guidance on the design of clinical trials in patients with ulcerative proctitis, the Definition and end points for ulcerative PROCtitis in clinical TRIALs consensus provides recommendations on the definition and endpoints for ulcerative proctitis clinical trials.
引用
- Caron B, Abreu MT, Siegel CA, et al. IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL Consensus. Clin Gastroenterol Hepatol. 2022. PMID: 35189386. doi:10.1016/j.cgh.2022.02.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。